HonCode

Go Back   HER2 Support Group Forums > Articles of Interest
Register Gallery FAQ Members List Calendar Search Today's Posts Mark Forums Read

Reply
 
Thread Tools Display Modes
Old 01-11-2022, 10:10 PM   #1
Nguyen
Senior Member
 
Join Date: Nov 2005
Posts: 531
Elacestrant Shines in EMERALD Trial

This is good news since most of us in the met setting likely have exhausted endocrine regimen!

https://www.clinicaloncology.com/Sol...LD-Trial/65629
Nguyen is offline   Reply With Quote
Old 10-21-2022, 09:28 AM   #2
Nguyen
Senior Member
 
Join Date: Nov 2005
Posts: 531
Elacestrant vs Fulvestrant or Aromatase Inhibitors for ER+/HER2− Advanced Breast Canc

If one is ER+ and has ESR1 mutation, it is possible for "cooperative" oncologist to use Elacestrant even if one is Her2+, especially when there is no endocrine regimen left.

Elacestrant vs fulvestrant or aromatase inhibitor (AI) in phase III trial evaluating elacestrant, an oral selective estrogen receptor degrader (SERD), vs standard of care (SOC) endocrine monotherapy for ER+/HER2- advanced/metastatic breast cancer (mBC): Subgroup analysis from EMERALD

https://www.annalsofoncology.org/art...110-X/fulltext
Nguyen is offline   Reply With Quote
Reply

Thread Tools
Display Modes

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is On

Forum Jump


All times are GMT -7. The time now is 09:45 AM.


Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021
free webpage hit counter